Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.680
+0.019 (0.41%)
At close: Feb 21, 2025, 4:00 PM
4.960
+0.280 (5.98%)
After-hours: Feb 21, 2025, 6:01 PM EST
Radiopharm Theranostics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -47.95 | -34.61 | -30.42 | -1.16 |
| Depreciation & Amortization | 3.13 | 3.3 | 2.98 | - |
| Loss (Gain) From Sale of Assets | 1.69 | - | - | - |
| Asset Writedown & Restructuring Costs | 1.48 | 3.1 | - | - |
| Stock-Based Compensation | 2.64 | 3.04 | 4.8 | 0.86 |
| Other Operating Activities | 8.99 | 3.81 | 10.48 | 0 |
| Change in Accounts Receivable | 3.48 | -4.28 | -0.05 | -0.02 |
| Change in Accounts Payable | 3.5 | 2.35 | 2.53 | 0.24 |
| Change in Other Net Operating Assets | 0.07 | 0.1 | -0.23 | - |
| Operating Cash Flow | -22.98 | -23.2 | -9.91 | -0.08 |
| Capital Expenditures | - | -0.05 | -0 | - |
| Sale (Purchase) of Intangibles | - | -1.49 | -28.34 | - |
| Investment in Securities | - | - | -0.04 | - |
| Investing Cash Flow | - | -1.53 | -28.38 | - |
| Short-Term Debt Issued | - | - | 0.01 | - |
| Long-Term Debt Issued | 7.37 | - | - | - |
| Total Debt Issued | 7.37 | - | 0.01 | 0.14 |
| Short-Term Debt Repaid | - | - | -0.07 | - |
| Long-Term Debt Repaid | -5.17 | - | - | - |
| Total Debt Repaid | -5.17 | - | -0.07 | - |
| Net Debt Issued (Repaid) | 2.2 | - | -0.06 | 0.14 |
| Issuance of Common Stock | 29.65 | 10.07 | 70 | 0 |
| Other Financing Activities | -1.97 | -0.85 | -4.83 | - |
| Financing Cash Flow | 29.88 | 9.22 | 65.11 | 0.14 |
| Foreign Exchange Rate Adjustments | -0.03 | 0.23 | 0.13 | - |
| Net Cash Flow | 6.88 | -15.28 | 26.95 | 0.07 |
| Free Cash Flow | -22.98 | -23.25 | -9.91 | -0.08 |
| Free Cash Flow Margin | -1173.12% | -374.36% | - | - |
| Free Cash Flow Per Share | -0.06 | -0.08 | -0.05 | - |
| Cash Income Tax Paid | -4.85 | -1.56 | - | - |
| Levered Free Cash Flow | -12.04 | -12.08 | -31.35 | - |
| Unlevered Free Cash Flow | -11.64 | -12.03 | -25.51 | - |
| Change in Net Working Capital | -4.67 | -1.03 | -7.5 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.